Royalty Pharma Cash Flow Statement (2019-2026) | RPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	221.80M	53.67M	128.08M	491.60M	220.41M	-610.03M	509.09M	351.34M	122.08M	717.59M	-4.27M	194.38M	806.36M	334.35M	434.43M	90.64M	444.21M	355.91M	468.26M	81.49M
Gains from Investment Securities (Quarter)	6.21M	6.17M	20.69M	6.81M	5.81M	5.83M	16.27M	2.24M	0.31M		13.40M		0.50M		13.40M	0.60M	0.90M		3.72M	21.02M
Asset Writedowns and Impairment (Quarter)																			69.40M
Cash from Operations (Quarter)																				728.46M
Investing Activities
Capital Expenditures (Quarter)																				251.02M
Acquisitions (Quarter)																	0.23M
Divestments (Quarter)																				-13.21M
Change in Acquisitions & Divestments (Quarter)																				4.32M
Cash from Investing Activities (Quarter)																				-229.72M
Financing Activities
Other financing activities (Quarter)																				-0.39M
Cash from Financing Activities (Quarter)																				-273.15M
Dividend Payments
Dividends Paid - Common (Quarter)																				34.59M
Additional items
Change in Cash (Quarter)																				225.59M
Free Cash Flow (Quarter)																				477.44M
Net Cash Flow (Quarter)																				225.59M